Protective effects of taurine on endothelial cells impaired by high glucose and oxidized low density lipoproteins
- 216 Downloads
Endothelial dysfunction, common to diabetes and cardiovascular diseases, is an early step in the development of atherosclerosis and diabetic angiopathies. Deficiencies of taurine have been related to diabetes and cardiovascular diseases.
Aims of the study
We investigated whether taurine provides protective action against endothelial dysfunction induced by hyperglycemia and/or oxidized low density lipoproteins (oxLDL).
Quiescent human umbilical cord venous endothelial cells were exposed for 20 h to high glucose (35 mM) and/or oxLDL (60 µg/ml) alone and in presence of taurine (0.5–2.5 mg/ml). Apoptosis, caspase-3 activity, soluble(s) and cell surface expressions of vascular cellular (VCAM-1) and intercellular (ICAM-1) adhesion molecules were determined. Results are given as a percentage of the low glucose medium control. Apoptosis, VCAM-1 and ICAM-1 expressions were related to cell number.
Hyperglycemia increased apoptosis to 162.5 ± 19.2%, caspase-3 activity to 153.2 ± 10.3%, cell-surface exp ression of VCAM-1 to 125.1 ± 5.8%, the expression of ICAM-1 to 123.7 ± 2.8% and sICAM-1 to 146.5 ± 7.9%. Taurine (0.5–2.5 mg/ml) restored apoptosis, caspase-3 activity and expressions of VCAM-1 and ICAM-1. OxLDL (60 µg/ml) increased apoptosis to 114.8 ± 3.1%; taurine (2.5 mg/ml) reduced this apoptosis to 40.5 ± 4.1%. The combination of hyperglycemia and oxLDL increased apoptosis to 211.7 ± 11.6%. This increase was normalized by taurine (2.5 mg/ml) to 97.9 ± 12.8%.
Taurine protects HUVECs from endothelial dysfunction induced by hyperglycemia through down-regulation of apoptosis and adhesion molecules. Counteracting the combination of oxLDL and hyperglycemia requires pharmacological concentrations of taurine.
Key wordstaurine endothelium oxLDL diabetes apoptosis adhesion molecules
The authors wish to thank the Deutsche Forschungsgemeinschaft (DFG)/Indian National Acadamy of Sciences (INSA) for their support of RR Bhonde as a visiting scientist under the DFG/INSA scientist exchange programme and Frederik Hartbrod for his excellent technical assistance.
- 4.Bombeli T, Schwarzt BR, Harlan JM (1999) Endothelial cells undergoing apoptosis become proadhesive for nonactivated platelets. Blood 93:3831–3838Google Scholar
- 12.Franconi F, Bennardini F, Mattana A, Miceli M, Ciuti M, Mian M, Gironi A, Antchini Ran, Seghierei G (1995) Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am J Clin Nutr 61:1115–1119Google Scholar
- 15.Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC Jr, Sowers JR (1999) Diabetes and cardiovascular disease: a statement for health professionals from the American Heart Association. Circulation 100:1134–1146Google Scholar
- 17.Hardikar AA, Risbud MV, Remacle C, Reusens B, Hoet JJ, Bhonde RR (2001) Islet cryopreservation: improved recovery following taurine pretreatment. Cell Transplant 10(3):247–253Google Scholar
- 18.Heitzer T, Ylä-Hertuala S, Luoma J et al (1996) Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 93:1346–1353Google Scholar
- 19.Ho FM, Liu SH, Lin WW, Liau CS (2007) opposite effects of high glucose on MMP-2 and TIMP-2 in human endothelial cells. J Cell Biol 101(2):442–450Google Scholar
- 20.Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72/1:101–163Google Scholar
- 27.Metzner C, Ulrich-Merzenich G (2001) Arginin und Taurin—präventive Nahrungsfaktoren bei kardiovaskulären Erkrankungen? Ernährungs-Umschau 48:188–192Google Scholar
- 31.Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y (1999) Novel Modulator for endothelial adhesion molecules. Adipocyte-derived plasma protein adiponectin. Circulation 100:2473–2476Google Scholar
- 34.Redmond HP, Wang JH, Bouchier-Hayes D (1996) Taurine attenuates nitric oxide and reactive oxygen intermediate-dependent hepatocyte injury. Arch Surg 131:1280–1288Google Scholar
- 35.Redmond HP, Wang JH, Watson RWG, Boucheier-Hayes D (1994) Restoration of “tired” neutrophil antimicrobial function by aprotinin is dependent on the presence of taurine. Surg Forum 80:573–575Google Scholar
- 36.Schwartz SM, Gajdusek CM, Selden SC III (1981) Vascular wall growth control. Arteriosclerosis 1:107–161Google Scholar
- 42.Wu CD, Wang JH, Fennessy F, Redmond HP, Bouchier-Hayes D (1999) Taurine prevents high glucose-induced human vascular endothelial cell apoptosis. Am J Physiol 277:C1229–C1238Google Scholar